The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
SOCIETY: AGA With the expansion of IBD treatment options, there is increasingly the need for predictive models to determine which treatments work best for which patients with IBD.
Presentations:
PROGNOSTICATION OF DISEASE COURSE IN IBD: THE PRESENT AND THE FUTURE
CAN CLINICAL PHENOTYPES AID IN PICKING THE RIGHT THERAPY FOR YOUR PATIENT?
STATISTICAL METHODS FOR THERAPEUTIC SEQUENCING: META-ANALYSES AND NETWORK META-ANALYSES
THE EMERGING ROLE OF MULTI-OMICS IN PERSONALIZING IBD THERAPY
SOCIETY: AGA While it is intuitive that inflammation of the bowel can be affected positively and negatively by diet, it is only recently that the underpinnings of diet on inflammatory bowel disease have been explored…
SOCIETY: AGA This session highlights the best of the best observational studies in IBD for DDW 2024 and provides clinical relevant and novel insights across the age and clinical spectrum, including wound healing after C-section…
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…